News

View all
Thumbnail image for US green light for AZ’ Lokelma

US green light for AZ’ Lokelma

US regulators have finally issued a green light for AstraZeneca’s Lokelma as a treatment for hyperkalaemia - elevated potassium levels in the blood - in adult patients.

21st May 2018

Thumbnail image for Data show ‘enduring’ benefits of GSK’s Nucala

Data show ‘enduring’ benefits of GSK’s Nucala

GlaxoSmithKline has released long-term data showing that its biologic Nucala significantly decreased exacerbations in patients with severe, eosinophilic asthma as well as improvement in disease control.

21st May 2018

Thumbnail image for EMA confirms risks of MS drug Zinbryta

EMA confirms risks of MS drug Zinbryta

The European Medicines Agency has concluded that the risks linked with use of Biogen and AbbVie's multiple sclerosis drug Zinbryta outweigh its benefits.

21st May 2018

Web Exclusives

View all
Thumbnail image for Being a woman in pharma

Being a woman in pharma

Two women in senior pharma leadership roles at talk about their career progression, their experience as women in the industry and progress for women generally

Thumbnail image for AI meets IP

AI meets IP

New machine learning technologies may have far-reaching, unexpected effects on IP and patent law

Thumbnail image for Trusting pharma

Trusting pharma

ViiV Healthcare has once again topped the annual PatientView corporate reputation survey. Dr Oleksandr Gorbenko, the company’s director, global patient affairs, explains the company’s views on how pharma should build trust with patients

Thumbnail image for SmartPeople: Bill Byrom

SmartPeople: Bill Byrom

With over 25 years experience in clinical development and as an eClinical thought leader and strategist, Bill Byrom is an expert on innovating clinical research. Now he has joined CRF Health as vice president of product strategy & innovation to define their product development vision

Thumbnail image for Pharma and data: Knowledge is power

Pharma and data: Knowledge is power

Sanofi’s Milind Kamkolkar is the first enterprise chief data officer in a major pharmaceutical company, and he has been outspoken about the need for pharma to adapt to the new digital world of AI, real-world evidence and prolific data. We caught up with him on the show floor at eyeforpharma Barcelona 2018

Thought Leadership

View all
Thumbnail image for AI in healthcare? 
Ask the patient

AI in healthcare? 
Ask the patient

It seems as if the conversation around the nature of healthcare’s AI future is one that’s been conducted without the voices of patients themselves

Thumbnail image for Baking in behaviour change

Baking in behaviour change

Patient support programmes (PSPs) provide one of the biggest opportunities for pharma to put a patient-centric philosophy into practice

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download